Observational Study To Evaluate Statins Patterns Of Use In Spain

July 23, 2013 updated by: AstraZeneca

Statins Use Patterns in Spain

The present project is aimed at describing the statins prescription pattern in Spanish patients. It will also look into how adequate these prescriptions are accordingly to the recommendations given in Treatment Guidelines and in the Summary Product Information.

Study Overview

Status

Withdrawn

Conditions

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

To be recruited by Primary Care Physicians

Description

Inclusion Criteria:

  • Patients receiving a new statin prescription (naïve patients)
  • Patients having a change in their statin prescription (dose, switching, addition to another hypolipemic drug)

Exclusion Criteria:

  • Patients without enough information in the medical records to complete the fields required in the eCRF

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
1
Adults, with a new statin prescription or a change in their stain treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Current and previous hypolipemic treatment, dose and pattern
Time Frame: Retrospectively (information for the previous 6-months). Information collected once.
Retrospectively (information for the previous 6-months). Information collected once.
Statin treatment start date, origin of the prescription, reasons for changes in prescription
Time Frame: Retrospectively (information for the previous 6-months). Information collected once.
Retrospectively (information for the previous 6-months). Information collected once.

Secondary Outcome Measures

Outcome Measure
Time Frame
Socio-demographic characteristics
Time Frame: retrospectively
retrospectively
Total Cholesterol, HDL, LDL, Triglycerides, ALAT, Glucose, Creatine Kinase plasma levels
Time Frame: retrospectively
retrospectively
Concomitant Treatments and Cardiovascular History
Time Frame: retrospectively
retrospectively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (ANTICIPATED)

April 1, 2012

Study Completion (ANTICIPATED)

July 1, 2012

Study Registration Dates

First Submitted

October 31, 2009

First Submitted That Met QC Criteria

December 1, 2009

First Posted (ESTIMATE)

December 2, 2009

Study Record Updates

Last Update Posted (ESTIMATE)

July 24, 2013

Last Update Submitted That Met QC Criteria

July 23, 2013

Last Verified

July 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe